Join Nataliya Andreychuk, CEO of Viseven, on Pharma Talks – a podcast where human voices meet industry insights. Dive into engaging conversations with industry leaders, exploring the latest trends in pharma marketing, digital transformation, and AI-driven solutions.
🔗 Follow Nataliya on LinkedIn for more updates and insights: https://www.linkedin.com/in/andreychuk/
🔗 Discover more about Viseven's digital solutions at viseven.com
In this episode recorded live at Fierce Pharma Week, Nataliya Andreychuk speaks with Ned Ehrbar, Director of Global Media Relations at Merck, about AI in pharma, medical-commercial collaboration, and the future of omnichannel pharmaceutical marketing.
They discuss why technology alone isn't enough, how workforce upskilling and new habits drive adoption, and why accurate, accessible, up-to-date information must remain at the center of every patient experience.
📲 Enjoyed this episode?
👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode
👉 Join our community: https://pharmatalks.circle.so/
👉 Want to be a guest? Plan your recording with Nataliya Andreychuk: https://pharma-talks.com/#be-guest
🔗 Follow & Connect:
🎙️ Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/
🎙️ Ned Ehrbar → https://www.linkedin.com/in/nedehrbar/
In Part 2 of this Pharma Talks episode, Nataliya Andreycuk continues her conversation with Rasmus Kalms, technologist and product leader, exploring the practical steps pharma teams can take to move beyond content production bottlenecks.
00:00 Rethinking the pharma content lifecycle with AI
03:41 Can early MLR approval cut content approval time by 50%?
07:00 Connecting platforms, teams and global content governance
10:54 Hot or Not
14:54 Delivering relevant, trustworthy content at the speed of need
16:13 Final advice: Don't be afraid to experiment
📲 Enjoyed this episode?
👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode
👉 Want to be a guest? Plan your recording with Nataliya Andreychuk
🔗 Follow & Connect:
🎙️ Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/
🎙️ Rasmus Kalms → https://www.linkedin.com/in/kalms/
Pharma doesn't necessarily need more content. It needs content that teams can find, reuse, adapt, and deliver when it's needed.
In Part 1 of this Pharma Talks conversation, Nataliya Andreycuk sits down with Rasmus Kalms, technologist and product leader, to challenge the way pharma approaches content production, modular content, and AI.
Why do content management practices that work in other industries often look different in pharma? Can generative AI solve the problem of fragmented content libraries? And is modular content really dead — or have we simply made it too complicated?
Rasmus shares his perspective on why a solid claims library, structured content, and transparent workflows are essential to making AI work in regulated environments. Together, Nataliya and Rasmus explore how pharma can rethink content operations, accelerate production, and build workflows that support both compliance and creativity.
00:00 Does pharma have a content graveyard problem?
04:03 Why pharma's approach to content may be part of the problem
08:55 From digital asset management to meaningful content reuse
14:41 Making modular content scalable with AI
16:08 Is compliance a constraint or an excuse for inaction?
📲 Enjoyed this episode?
👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode
👉 Want to be a guest? Plan your recording with Nataliya Andreychuk
🔗 Follow & Connect:
🎙️ Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/
🎙️ Rasmus Kalms → https://www.linkedin.com/in/kalms/
In this episode recorded live at Fierce Pharma Week, Nataliya Andreychuk speaks with Ned Ehrbar, Director of Global Media Relations at Merck, about AI in pharma, medical-commercial collaboration, and the future of omnichannel pharmaceutical marketing.
They discuss why technology alone isn't enough, how workforce upskilling and new habits drive adoption, and why accurate, accessible, up-to-date information must remain at the center of every patient experience.
📲 Enjoyed this episode?
👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode
👉 Join our community: https://pharmatalks.circle.so/
👉 Want to be a guest? Plan your recording with Nataliya Andreychuk: https://pharma-talks.com/#be-guest
🔗 Follow & Connect:
🎙️ Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/
🎙️ Ned Ehrbar → https://www.linkedin.com/in/nedehrbar/
In Part 2 of this Pharma Talks episode, Nataliya Andreycuk continues her conversation with Rasmus Kalms, technologist and product leader, exploring the practical steps pharma teams can take to move beyond content production bottlenecks.
00:00 Rethinking the pharma content lifecycle with AI
03:41 Can early MLR approval cut content approval time by 50%?
07:00 Connecting platforms, teams and global content governance
10:54 Hot or Not
14:54 Delivering relevant, trustworthy content at the speed of need
16:13 Final advice: Don't be afraid to experiment
📲 Enjoyed this episode?
👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode
👉 Want to be a guest? Plan your recording with Nataliya Andreychuk
🔗 Follow & Connect:
🎙️ Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/
🎙️ Rasmus Kalms → https://www.linkedin.com/in/kalms/
Pharma doesn't necessarily need more content. It needs content that teams can find, reuse, adapt, and deliver when it's needed.
In Part 1 of this Pharma Talks conversation, Nataliya Andreycuk sits down with Rasmus Kalms, technologist and product leader, to challenge the way pharma approaches content production, modular content, and AI.
Why do content management practices that work in other industries often look different in pharma? Can generative AI solve the problem of fragmented content libraries? And is modular content really dead — or have we simply made it too complicated?
Rasmus shares his perspective on why a solid claims library, structured content, and transparent workflows are essential to making AI work in regulated environments. Together, Nataliya and Rasmus explore how pharma can rethink content operations, accelerate production, and build workflows that support both compliance and creativity.
00:00 Does pharma have a content graveyard problem?
04:03 Why pharma's approach to content may be part of the problem
08:55 From digital asset management to meaningful content reuse
14:41 Making modular content scalable with AI
16:08 Is compliance a constraint or an excuse for inaction?
📲 Enjoyed this episode?
👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode
👉 Want to be a guest? Plan your recording with Nataliya Andreychuk
🔗 Follow & Connect:
🎙️ Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/
🎙️ Rasmus Kalms → https://www.linkedin.com/in/kalms/
Nataliya Andreychuk sits down with Raphael Blum, oncology commercial executive and former VP, Global Commercial Development Oncology at AbbVie, to look at why an industry that saves lives still struggles to earn public trust. After more than 20 years at Pfizer, Merck Serono and AbbVie, starting as a medical rep, Raphael has worked on both sides of the trust gap: in headquarters and in the field.
Key takeaways:
Trust in a medicine or a physician is different from trust in a company or an industryExplaining risk has never been enough, because patients judge pharma through access, affordability and their own treatment pathwayAccountability for trust starts with leadership: priorities, incentives and the trade-offs a company acceptsGlobal launch plans need local input from day one, not after the strategy is finishedWith fewer than 5% of oncology programs reaching approval, the cost of failure sits inside every price📲 Enjoyed this episode? 👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode
🔗 Follow & Connect: 🎙️ Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/ 🎙️ Raphael Blum → LinkedIn
AI is changing more than the technology inside pharma's software stack. It is challenging the entire SaaS model: how software is built, how workflows are designed, how teams work, and what customers should actually pay for.
In this episode of Pharma Talks, Nataliya Andreychuk sits down with Thomas Mrosk, a pharma and AI transformation expert and co-founder of CTC Health, to explore what is changing — and what pharma needs to rethink next.
From fragmented point solutions and traditional SaaS models to agentic AI, internal capabilities and AI-powered education, this conversation asks a bigger question:
Are we really transforming pharma — or just adding AI features to old ways of working?
00:00 How AI Is Changing the Rules of the SaaS Game
07:04 Is the Classical SaaS Model Dead?
09:08 Build vs. Buy: Where Should Pharma Build AI Capabilities?
12:50 Bringing Software, Services & Expertise Together
17:50 How AI Could Reimagine Pharma Education
22:22 Hot or Not: The Future of Pharma Martech
25:01 Content at the Speed of Need
27:00 Thomas Mrosk's Advice: Demand Outcomes
📲 Enjoyed this episode?
👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode
👉 Want to be a guest? Plan your recording with Nataliya Andreychuk.
🔗 Follow & Connect:
🎙️ Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/
🎙️ Thomas Mrosk → https://www.linkedin.com/in/thomas-mrosk/
#PharmaAI #SaaS #AgenticAI #DigitalTransformation #PharmaMarTech
In this episode of Pharma Talks, Nataliya Andreychuk sits down with Toby Beaumont, a commercial digital transformation expert who has spent around 20 years working across pharma, agencies, and the vendor side, to unpack one of the biggest challenges facing pharma marketing today:
AI can generate content faster than ever. But what happens when you put a faster engine into a broken car?
The conversation explores what pharma needs to fix before it can truly scale AI — and what it could mean for the future of pharma marketing and the marketer of tomorrow.
00:00 Systematic to Automatic — Why AI Alone Won't Transform Pharma
02:00 The Problem With Fragmentation
07:00 Building the Content System — Design Systems, Metadata & Guardrails
14:00 AI, Scale & the Marketer of Tomorrow
20:00 Efficiency ≠ Effectiveness
26:00 Where to Start — Experimentation, Measurement & Scalability
📲 Enjoyed this episode?
👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode
👉 Want to be a guest? Plan your recording with Nataliya Andreychuk.
🔗 Follow & Connect:
🎙️ Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/
🎙️ Toby Beaumont → https://www.linkedin.com/in/tobybeaumont/
In Part 2 of this Pharma Talks conversation, Nataliya Andreychuk and Richard Schwartz continue their discussion about why experience is medicine — and explore what technology, data, and AI could mean for the future of healthcare experiences.
From rethinking brand websites and using AI to understand the questions patients are really asking, to challenging pharma's approach to HCP engagement, patient support, and measurement, Richard argues that the industry has an opportunity to create experiences that are as sophisticated as the science behind the medicines.
The conversation also explores the potential of agentic AI in healthcare — from helping with prior authorization and prescription access to coordinating delivery and patient education — and why making this future possible will require greater cooperation across the healthcare ecosystem.
00:00 AI & the future of healthcare experience
02:27 From search to questions
04:28 Hot or Not: fewer, better communications
07:00 Data-rich, value-poor?
11:34 Rethinking patient support
15:37 Measuring what matters
21:12 Real-time experience & agentic AI
24:00 How to make experience part of the plan
📲 Enjoyed this episode?
👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode
👉 Want to be a guest? Plan your recording with Nataliya Andreychuk
🔗 Follow & Connect:
🎙️ Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/
🎙️ Richard Schwartz → https://www.linkedin.com/in/richardpschwartz/
What happens between a pharmaceutical product and the patient who needs it?
In Part 1 of this Pharma Talks conversation, Nataliya Andreychuk sits down with Richard Schwartz, a healthcare and pharmaceutical industry expert with three decades of experience across pharma, consulting, agencies, publishing and technology, to explore one of the industry's biggest blind spots: the experience surrounding the medicine.
The conversation goes deeper into trust in pharma, patient-centricity, healthcare customer experience, patient support programs and why experience should be treated as part of the product — not an extra layer added after the medicine is developed.
00:00 Experience as a medicine
03:20 Trust: the metric pharma can't ignore
10:12 The "Healthcare Pea Soup"
14:11 Design the experience from day one
18:52 AI, empathy & the human advantage
26:55 The rise of digital opinion leaders
📲 Enjoyed this episode?
👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode
👉 Want to be a guest? Plan your recording with Nataliya Andreychuk
🔗 Follow & Connect:
🎙️ Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/
🎙️ Richard Schwartz → https://www.linkedin.com/in/richardpschwartz/
In this solo episode of Pharma Talks, Nataliya Andreychuk takes an unfiltered look at one of the biggest challenges emerging from AI adoption in the pharmaceutical industry: the velocity trap.
Pharma is investing billions in artificial intelligence, accelerating content production, expanding into new channels, and making localization easier than ever. Yet at the same time, huge volumes of approved content are never used.
Nataliya explores what happens when AI-powered content creation moves faster than the workflows, relationships, and human expertise needed to make that content meaningful. She looks at the gap between content production and HCP engagement, the role of AI-native pharma organizations, and why AI may be exposing — rather than solving — broken pharmaceutical content workflows.
The conversation also introduces the HUMICS framework and explores the uniquely human capabilities that will become even more important in an AI-native pharmaceutical organization.
00:00 Welcome to a solo episode of Pharma Talks
00:07 Pharma’s massive AI investment and the race for efficiency
02:00 The AI content “velocity trap”
04:00 Why more content doesn’t necessarily mean more engagement
06:00 AI-native pharma and the future of human expertise
08:00 The HUMICS framework
10:00 Human-in-the-loop, MLR and compliant AI
12:00 The AI roadmap pharma leaders should be building
📲 Enjoyed this episode?
👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode
👉 Want to be a guest? Plan your recording with Nataliya Andreychuk.
🔗 Follow & Connect:
🎙️ Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/
Steve Swan returns to Pharma Talks for a conversation about what has changed in pharma talent and recruitment since his last conversation with Nataliya Andreychuk a year ago.
And the answer is: a lot.
AI is now writing job descriptions, tailoring resumes, screening candidates — and, in some cases, essentially creating an AI-versus-AI recruitment loop. The result? Hundreds of polished applications, but not necessarily more people who can actually do the job.
With nearly 30 years of experience hiring across pharma and biotech, Steve shares what he is seeing from the front lines — from the growing demand for AI talent to the rise of "AI-native" professionals and the new role of humans in an increasingly AI-driven workplace.
Chapters:
0:00 AI is already changing recruitment
4:13 The AI recruitment loop: when AI starts checking its own homework
11:37 Are AI-native professionals the next generation of pharma talent?
15:05 The "bionic employee" and why human intelligence still matters
19:38 Hot or Not: Is pharma already losing the AI talent race?
24:32 Can pharma compete with Big Tech for AI talent?
25:06 Where will the next pharma talent wave come from?
📲 Enjoyed this episode?
👉 Like, subscribe & hit the 🔔 to never miss a Pharma Talks episode.
👉 Have a question about hiring, recruiting or building AI talent in pharma and biotech? Send it our way — we're listening.
🔗 Follow & Connect:
🎙️ Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/
🎙️ Steve Swan → https://www.linkedin.com/in/swangroup/
Part 2 of this Pharma Talks conversation with Elaine Gamble moves from identifying the challenges of Commercial and Medical collaboration to the practical steps organizations can take to create connected customer experiences.
The discussion explores how AI, next best action, customer data, and organizational culture can help pharma teams work as one — without compromising compliance or scientific integrity.
📲 Enjoyed this episode?
👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode.
👉 Want to be a guest? Plan your recording with Nataliya Andreychuk.
🔗 Follow & Connect: 🎙️ Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/ 🎙️ Elaine Gamble → https://www.linkedin.com/in/elainegamble/
Elaine Gamble, customer engagement leader, omnichannel strategist, and former executive at Merck, Novartis, Otsuka, and other leading pharmaceutical companies, joins Nataliya Andreychuk on Pharma Talks to explore why stronger collaboration between Commercial and Medical has become essential for delivering connected, compliant, and customer-centric engagement.
In Part 1, Elaine explains why silos still exist despite years of digital transformation—and why technology isn't the biggest barrier.
Key takeaways:
Commercial and Medical teams often share the same goals but operate through transactional relationships instead of true collaboration.Leadership, culture, and shared initiatives — not incentives alone — are the foundation of effective cross-functional alignment.MSL insights remain one of pharma's most underutilized assets and can significantly improve commercial engagement when shared appropriately.AI, orchestration, and omnichannel capabilities already exist to support collaboration — but many organizations are still underusing them.The future of customer engagement depends on seeing one healthcare professional through one connected customer journey.Discover how leading pharma organizations can move beyond silos and build stronger Commercial and Medical partnerships that create more meaningful healthcare professional experiences.
Explore why pharma needs stronger Commercial and Medical collaboration to deliver connected, compliant, and customer-centric engagement.
📲 Enjoyed this episode?
👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode.
👉 Want to be a guest? Plan your recording with Nataliya Andreychuk.
🔗 Follow & Connect:
🎙️ Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/
🎙️ Elaine Gamble → https://www.linkedin.com/in/elainegamble/
Part 2 of this Pharma Talks conversation with Matteo Colonna picks up where strategy meets execution — moving from the "why" of omnichannel and AI to the practical realities of making it work inside pharma organizations.
📲 Enjoyed this episode?
👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode
👉 Want to be a guest? Plan your recording with Nataliya Andreychuk
🔗 Follow & Connect:
🎙️ Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/
🎙️ Matteo Colonna → https://www.linkedin.com/in/colonnamatteo/
Matteo Colonna, an omnichannel transformation practitioner with a background in theoretical physics from Sapienza University in Rome and experience across consulting, digital agencies, and two major pharma companies, joins Nataliya Andreychuk on Pharma Talks to unpack why omnichannel and AI have moved from "nice to have" to business necessity.
Key takeaways:
Customer behavior and expectations have fundamentally shifted — pharma companies can no longer design omnichannel experiences without first understanding what customers actually need and prefer.Technology should never be the starting point — the right approach begins with identifying the business or customer problem, then working backward to the technology that solves it.Omnichannel and AI transformation is no longer a technology project — it's a full business transformation that touches strategy, structure, and mindset.Real omnichannel execution requires bridging strategy and day-to-day operations, not just designing frameworks on paper.Explore how pharma teams move from omnichannel strategies to execution and where AI creates real value across content, insights, and engagement.
📲 Enjoyed this episode?
👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode
👉 Want to be a guest? Plan your recording with Nataliya Andreychuk
🔗 Follow & Connect:
🎙️ Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/
🎙️ Matteo Colonna → https://www.linkedin.com/in/colonnamatteo/
Karol Wolak, Director and Global Omnichannel Excellence Lead at Merck, joins Nataliya Andreychuk on Pharma Talks to tackle a question on everyone's mind: is AI coming for pharma jobs? His perspective is grounded in hands-on work across customer engagement and digital transformation at one of the industry's largest organizations.
Views shared are Karol Wolak's own and do not represent an official position of Merck.
Key takeaways:
AI isn't replacing pharma roles anytime soon — it's better positioned to absorb repetitive back-office work like content tagging, MLR approval, and data collection.Human qualities — context, ethics, judgment, empathy — remain outside what AI can deliver, especially in a highly regulated industry.The environmental cost of AI, from data storage to energy consumption, is a factor the industry rarely puts on the table.Patient-centricity stays the anchor point for every engagement decision, regardless of which technology sits behind it.Staying engaged and experimenting with AI beats waiting on the sidelines — but balance matters more than volume.Chapters: 0:00 Cold open — "AI will not replace us, at least not now" 0:51 Karol Wolak on the shift from multichannel to omnichannel at Merck 1:49 Why patients are the real center of pharma engagement 3:33 Does AI take our jobs? The blunt answer 5:02 Resource optimization: where AI actually helps pharma teams 7:14 The environmental cost of AI no one talks about 9:18 Finding the balance between innovation and human survival 13:06 Advice for listeners: don't wait on the sidelines
📲 Enjoyed this episode? 👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode 👉 Want to be a guest? Plan your recording with Nataliya Andreychuk at NEXT Pharma Summit (Dubrovnik)
🔗 Follow & Connect: 🎙️ Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/ 🎙️ Karol Wolak → https://www.linkedin.com/in/karolwolak/
Agentic AI has moved pharma from answering questions to autonomously orchestrating entire workflows — but most organisations are still building the foundations it needs to run well. In this episode, Nataliya Andreychuk talks with Michal Dojlidko about what agentic AI actually requires in practice: the right data, the right guardrails, continuous upskilling, and a clear-eyed view of where humans still belong in the loop.
Key topics
Evolution of AI in pharma from answering questions to autonomous workflows
Importance of trust and data foundations in AI adoption
Regulatory considerations and human oversight in agentic AI
Future roles of humans as strategists and overseers of AI
Technological advancements enabling secure, scalable AI solutions
Chapters
00:00 Introduction to Agentic AI in Pharma Marketing
00:55 Evolution of AI in Pharma
02:34 The Shift to Autonomous AI
03:49 Reimagining Workflows with AI
05:10 Building Trust in AI
06:23 Data Foundations for AI Success
07:47 Continuous Learning and AI Literacy
09:31 The Future Role of Humans in AI
12:19 Security and Compliance in AI
14:11 Human Oversight in Regulated Industries
15:56 Hot or Not: AI Statements
23:45 Conclusion and Key Takeaways
Discover more platforms to listen to this podcast: https://rss.com/podcasts/pharma-talks/
***
Follow Viseven, Nataliya, and Michal in social media:
https://www.linkedin.com/company/2907491
https://www.linkedin.com/in/andreychuk/
https://www.linkedin.com/in/mdojlidko/
Michael Kirzhner, Omnichannel Platforms and Capabilities Leader at AbbVie, joins Nataliya Andreychuk to discuss the real state of omnichannel in pharma — what the industry has built, what's still missing, and where the next evolution lies.
Michael has spent over a decade navigating the shift from field-centric models to digital-first orchestration inside one of the world's largest pharma companies.
In this episode:
Omnichannel fragmentation starts with departments, not technology — the coordination layer is what pharma hasn't built yet
Most companies are strong at functional execution but lack a central decisioning function that cuts across channels
Digital opinion leaders are outpacing traditional KOLs because they've mastered the channels pharma is still learning
Patient services is facing the same orchestration challenge commercial solved — and the stakes are higher
AI's real value isn't automation — it's closing the gaps in personalization, decisioning, and content throughput that were previously impossible at scale
📲 Enjoyed this episode?
👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode
👉 Want to be a guest? Plan your recording with Nataliya Andreychuk at NEXT Pharma Summit (Dubrovnik)
🔗 Follow & Connect:
🎙 Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/
🎙 Michael Kirzhner → https://www.linkedin.com/in/michaelkirzhner/
In this episode of Pharma Talks, recorded live at NEXT Pharma Summit in Dubrovnik, Nataliya Andreychuk speaks with Jennifer Cleall, Global Head of Digital Transformation at Ferring Pharmaceuticals, on what it actually takes to align medical and commercial teams — and where AI fits into that picture.
Jennifer brings cross-industry perspective spanning pharma, med tech, and enterprise technology.
Key takeaways:
AI won't take our jobs — but being deliberate about where and why you apply it is what separates progress from noise
Before layering in AI, organizations need to simplify processes and systems first — technology won't fix broken foundations
AI can act as an enabler for medical-commercial alignment, but directional clarity on where you're headed has to come first
The goal hasn't changed: showing up with relevance and trust for HCPs to improve patient outcomes
Digitizing what exists today is not the destination — the real question is where pharma needs to be in five to ten years
📲 Enjoyed this episode?
👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode
👉 Want to be a guest? Plan your recording with Nataliya Andreychuk: https://www.linkedin.com/in/andreychuk/
In this episode Laragh De Bhulbh shares her expertise on breaking down silos within pharma organizations, fostering cross-functional collaboration, and implementing strategic frameworks to enhance medical affairs. Discover practical tips for leaders and the importance of trust, communication, and strategic alignment in driving patient impact.
Key topics:
- Cross-functional collaboration challenges in pharma
- The Catalyst framework for alignment
- Leadership strategies for medical affairs
- The role of trust and communication
Chapters
00:00 Introduction to Laragh De Bhulbh and her expertise
01:24 Lara's background and motivation for improving pharma collaboration
02:21 The evolution of medical affairs and organizational alignment
03:27 Challenges in integrating medical and commercial functions
06:10 Overcoming silos: trust, safety, and open communication
10:04 The Catalyst framework: eight pillars for cross-functional success
12:42 The importance of omnichannel communication and rapid pivoting
15:59 Leadership tips for fostering collaboration and strategic clarity
17:43 Quick reactions: what is hot or not in pharma collaboration
19:18 Final thoughts: clarity and communication as game changers
Discover more platforms to listen to this podcast: https://rss.com/podcasts/pharma-talks/
***
Follow Viseven, Nataliya, and Laragh in social media:
https://www.linkedin.com/company/2907491
https://www.linkedin.com/in/andreychuk/
https://www.linkedin.com/in/ldeb/
In this episode of Pharma Talks, recorded live at NEXT Pharma Summit in Dubrovnik, Nataliya Andreychuk speaks with Michael Kurr, a global transformation leader with 15+ years building large-scale commercial and medical affairs operations at Novartis and Boehringer Ingelheim, on what delivery at scale actually looks like in the AI era.
Michael built content and delivery organizations of over 1,000 people — and he has some of the most direct takes on where pharma transformation is stalling.
Key takeaways:
Modular content served its purpose as a scalability crutch — but well-trained AI models will eventually make it obsoleteMLR is a bottleneck not just because of technology, but because of trust — local approvers carry legal liability and need confidence in what they sign offAI systems must become more explainable and deterministic before pharma can rely on AI-generated and AI-approved contentThe King Kong principle: having content is the easier part — getting the right content to the right customer at the right time, at scale, is the real challengeStaying relevant and staying current is the only viable strategy for individuals navigating AI-driven transformation📲 Enjoyed this episode? 👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode 👉 Want to be a guest? Plan your recording with Nataliya Andreychuk at NEXT Pharma Summit (Dubrovnik)
🔗 Follow & Connect: 🎙️ Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/ 🎙️ Michael Kurr → https://www.linkedin.com/in/michaelkurr/
In this episode of Pharma Talks, recorded live at NEXT Pharma Summit in Dubrovnik, Nataliya Andreychuk speaks with Lauren Leahy, who leads global and international medical capabilities operations, on what AI really means for the people working inside pharma today.
Lauren brings a medical affairs perspective to a conversation that's usually dominated by commercial voices.
Key takeaways:
AI isn't eliminating jobs — but it is fundamentally changing how they're structured and what skills they demandIn omnichannel, AI is actually increasing workload in the short term as teams redesign processes and upskillThe real opportunity isn't just productivity gains — it's system-level change and improved output qualityMedical and commercial functions need to work closer together around a single customer experienceStaying curious and adaptable — at both individual and company level — is the core competency for navigating what's ahead📲 Enjoyed this episode? 👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode 👉 Want to be a guest? Plan your recording with Nataliya Andreychuk
🔗 Follow & Connect: 🎙️ Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/
In this episode of Pharma Talks, recorded live at NEXT Pharma Summit in Dubrovnik, Nataliya Andreychuk sits down with Laetitia Huret, Lead of Transformation at Servier, to explore what AI-driven commercial excellence actually looks like on the ground.
Laetitia Huret works across global-to-local transformation, helping teams navigate digital, data, and AI change in the sales and commercial space.
Key takeaways:
The real question isn't whether AI will replace jobs — it's whether we're willing to keep ways of working that can be replacedAI's value in pharma lies in augmenting HCP engagement, not just accelerating content volumeHuman experience and accumulated knowledge remain the irreplaceable edge in an AI-assisted environmentEmbracing agentic and generative AI tools requires genuine investment in understanding them — not expecting magicThose not actively adopting AI risk falling behind in an industry-wide shift already underway📲 Enjoyed this episode? 👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode 👉 Want to be a guest? Plan your recording with Nataliya Andreychuk
🔗 Follow & Connect: 🎙️ Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/
Watch the first part of the conversation: https://youtu.be/PtR62juQ4FY
This episode Nataliya Andreychuk with guests explores the impact of AI on pharma marketing and communication, emphasizing the importance of human oversight, regional differences in Asia, and practical strategies for global-to-local adaptation.
👥 Guests in this episode:
Bruno Senouci - co-CEO at DRCOM
Gwenael Meneux - co-CEO at DRCOM
Key Topics:
AI impact on pharma communication
Regional differences in Asia healthcare markets
Global to local content adaptation strategies
Contact Viseven experts to elevate your healthcare marketing strategy: https://viseven.com/contact-us/
Follow Viseven and Nataliya, Bruno and Gwenael in social media:
https://www.linkedin.com/in/andreychuk/
https://www.linkedin.com/in/bsenouci/
https://www.linkedin.com/in/gwenael-meneux/?locale=fr
Watch the second part of the conversation: https://youtu.be/9wQPF4W6qNQ
This episode Nataliya Andreychuk with guests explores the impact of AI on pharma marketing and communication, emphasizing the importance of human oversight, regional differences in Asia, and practical strategies for global-to-local adaptation.
👥 Guests in this episode:
Bruno Senouci - co-CEO at DRCOM
Gwenael Meneux - co-CEO at DRCOM
Key Topics:
AI impact on pharma communication
Regional differences in Asia healthcare markets
Global to local content adaptation strategies
Follow Viseven and Nataliya, Bruno and Gwenael in social media:
https://www.linkedin.com/in/andreychuk/
https://www.linkedin.com/in/bsenouci/
https://www.linkedin.com/in/gwenael-meneux/?locale=fr
In this episode recorded live at the Reuters event in Barcelona, Nataliya Andreychuk sits down with Vanitha Venkatasubramaniam, Associate Director at Novo Nordisk, for an honest conversation about where pharma stands today with AI — and where the real opportunity lies ahead.
Vanitha brings a refreshingly balanced view: the skills aren't fully there yet, but the intention from leadership is. And the most exciting work? Using AI to genuinely improve the experience for HCPs and patients.
Key takeaways:
AI adoption in pharma is accelerating faster than most teams are ready for
Leadership intent is strong — but building the right skills across teams remains the gap
Generative AI is already embedded in day-to-day workflows — Copilot, emails, meetings
The biggest opportunity is using AI to enhance experiences for HCPs and patients, not just internal efficiency
Think beyond existing marketing models — combine them with technology to create innovative go-to-market approaches
📲 Enjoyed this episode?
👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode
👉 Want to be a guest? Plan your recording with Nataliya Andreychuk at NEXT Pharma Summit (Dubrovnik)
In this episode recorded live at the Reuters event in Barcelona, Nataliya Andreychuk sits down with Maryna Alexeychuk, Head of Strategic Accounts at Viseven, for a grounded take on what AI in pharma marketing should actually look like in practice.
Her message is clear: AI shouldn't be a separate initiative — it should live inside the tools and processes marketers already use every day.
Key takeaways:
AI should be embedded where marketers already work — content, campaigns, reportingContextual, always-on AI beats standalone tools nobody opens twiceAI won't replace pharma marketers — human context in engagement is irreplaceableBefore choosing a technology, map your end-to-end processes and define your goal first📲 Enjoyed this episode? 👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode 👉 Want to be a guest? Plan your recording with Nataliya Andreychuk at NEXT Pharma Summit (Dubrovnik)
In this episode, host Nataliya Andreychuk sits down with three industry experts for honest, unfiltered conversations about how AI is reshaping the pharmaceutical industry — from content supply chains to market access and beyond. 👥 Guest in this episode: Marc Koolen - Omnichannel Head GSK Follow Viseven and Nataliya and Marck in social media: https://www.linkedin.com/in/andreychuk/ https://www.linkedin.com/in/marc-koolen/
In this episode recorded live at the Reuters event in Barcelona, Nataliya Andreychuk sits down with Haider Alleg, pharma strategist turned venture capitalist at Allegory Capital, to explore why AI in pharma commercial operations is still mostly noise — and what it will actually take to change that.
With 20 years in pharma and a fresh perspective from the VC world, Haider cuts through the hype and makes a bold claim: this isn't a technology shift. It's a culture shift.
Key takeaways:
AI in R&D and manufacturing is already mature — commercial operations are just catching up
Dark factories and agentic systems show what full automation can look like
The biggest opportunity isn't automating tasks — it's re-internalizing operational work with AI
Medical and scientific affairs are best positioned to lead the way right now
The advice that matters most: get your hands dirty and stay curious
📲 Enjoyed this episode?
👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode
👉 Want to be a guest? Plan your recording with Nataliya Andreychuk at NEXT Pharma Summit (Dubrovnik)
🔗 Follow & Connect:
🎙️ Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/
🎙️ Haider Alleg → https://www.linkedin.com/in/haideralleg/
In this episode recorded live at the Reuters event in Barcelona, Nataliya Andreychuk sits down with Yacin Marzouki, Founder and Leader of Beyond Health, to explore how AI is truly reshaping pharma marketing — and why the real transformation goes far deeper than individual pilots or content tools.
Key takeaways:
- AI in pharma marketing requires systemic thinking, not point solutions
- Content without a delivery strategy is content that collects dust
- Modular content isn't dead — it's just often implemented too early
- Data hygiene and taxonomy are the boring work that makes everything else possible
--
📲 Enjoyed this episode?
👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode
👉 Want to be a guest? Plan your recording with Nataliya Andreychuk at NEXT Pharma Summit (Dubrovnik)
--
🔗 Follow & Connect:
🎙 Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/
🎙 Yacin Marzouki → https://www.linkedin.com/in/yacin-m-customerengagement/
Pharma has invested heavily in digital, CRM, and omnichannel — and yet the HCP engagement gap persists. In this episode, Nataliya Andreychuk talks with Mark Watson (Fractal Force) about why the problem is structural, not a failure of effort, and what it genuinely takes to close it: from fixing broken feedback loops to defining what "working" actually means
at the behaviour level.
Key Topics:
The gap between digital investment and actual engagement results
The importance of foundational architecture in customer engagement
The role of feedback loops in improving HCP interactions
Challenges of content personalization and regulation in pharma
Strategic content design and journey logic in omnichannel marketing
Chapters
00:00 Introduction to Customer Engagement Challenges
02:22 Understanding the Gap in Pharma Engagement
05:01 The Evolution of Customer Centricity
07:56 Architecting Effective Engagement Strategies
10:47 Content Creation and Regulatory Challenges
13:45 Intelligent Content Design for Better Engagement
16:25 Building a Feedback Loop for Success
18:01 Making Engagement Real and Effective
20:52 Practical Steps for Transformation
23:33 Final Thoughts and Recommendations
Follow Nataliya Andreychuk and Mark in social media:
https://www.linkedin.com/in/andreychuk/
linkedin.com/in/markwatsonuk
In this episode, host Nataliya Andreychuk sits down with three industry experts for honest, unfiltered conversations about how AI is reshaping the pharmaceutical industry — from content supply chains to market access and beyond.
👥 Guests in this episode:
Rohit Khuttan — Practice Director, Everest Group
On AI, Omnichannel, content as the central piece of pharma engagement, and why enterprise mindset is the #1 thing that needs to change.
Ruslan Horblyuk — Chief Strategy Officer, AESARA
On AI in market access, health technology assessments, trust in AI data, and whether human-in-the-loop will always be necessary.
Nihar Patel — Business Development, Sun Pharma
On generative, predictive and communicative AI, breaking data silos, and the three pharma areas set for the biggest disruption.
Key topics covered:
Is Omnichannel really a content problem, not a channel problem?
How AI is changing content production and the pharma supply chain
Can we trust AI data in market access decisions?
Will AI replace pharma professionals — or make them smarter?
The three pharma disciplines AI will disrupt first
📲 Enjoyed this episode?
👉 Like, Subscribe & hit the to never miss a Pharma Talks episode
👉 Want to be a guest? Plan your recording with Nataliya Andreychuk at Reuters Pharma Barcelona
In this episode of Pharma Talks, Natalyia Andreychuk and Anna Shavurska explore trust in AI, especially agentic AI in pharma, the importance of women in tech, and how AI can be developed responsibly with a focus on safety, trust, and diversity.
Takeaways:
Trust in agentic AI and safety measures in pharma
The importance of women in AI development and diversity
Technical approaches to secure and reliable AI, including knowledge bases and retrieval-augmented generation
Chapters
00:00 Introduction to AI Trust and Women in Tech
02:00 Understanding Agentic AI and Knowledge Base Security
03:45 Ensuring Data Privacy and Trust in Pharma AI
05:39 Technical Challenges in Visual and Text Generation
07:35 Prompt Engineering and AI Output Precision
09:50 The Importance of Women in AI Development
11:38 Historical Bias and the Need for Diversity in AI
12:39 Inspiration and Career Path in AI
13:30 Closing Remarks and Future of Women in AI
Content Supply Chain in Pharma | Pharma Talks
In this conversation, Nataliya Andreychuk and Prasant Vijayakumar discuss the importance of the content supply chain in the pharmaceutical industry, exploring how AI is transforming content development, the relevance of modular content, and the challenges faced in ensuring effective engagement.
Takeaways
Content supply chain is crucial for effective communication in pharma. AI is changing the landscape of content development. MLR processes can be streamlined to enhance efficiency. Modular content remains relevant in today's digital age. Structured data is essential for effective content management. Content velocity affects how quickly updates can be communicated. Localization is key to successful content adoption. Integration of various content formats is necessary for engagement. The future of content creation will involve more video formats. Challenging the status quo of MLR can lead to significant improvements.
Chapters
00:00 Introduction to Content Supply Chain in Pharma 02:18 The Role of AI in Content Development 05:11 Modular Content: Relevance and Education 07:50 Challenges in Content Structure and Data 10:26 Content Velocity and Engagement 13:03 The Future of Content Supply Chain 15:58 Localization and Infrastructure in Content Delivery 18:50 Conclusion and Future Outlook
Contact Viseven experts to elevate your healthcare marketing strategy: https://viseven.com/contact-us/ Discover more platforms to listen to this podcast: https://rss.com/podcasts/pharma-talks/
In this episode of PharmaTalks, Nataliya Andreychuk explores the rise of digital opinion leaders with pharma omnichannel and digital engagement expert Pavlo Klymenko.
The conversation goes beyond influencers and traditional key opinion leaders, focusing on a new type of voice emerging naturally in open and social media. Clinicians who build trust, share practical experience, and engage peers and patients in a more open, continuous way.
Takeaways
Digital opinion leaders are more than just influencers; they provide credible medical information.There is a significant gap between guidelines and real-world practices in healthcare.Patients increasingly seek information from social media rather than healthcare professionals.Effective communication requires constant dialogue with clinicians.Digital opinion leaders can help fill the gap left by misinformation online.Pharma must adapt to the fast-paced changes in healthcare communication.Engagement with digital opinion leaders should be honest and transparent.The role of digital opinion leaders is essential for product launch readiness.Pharma companies need to invest time and resources in building relationships with digital opinion leaders.Creating reusable content for digital opinion leaders can enhance communication efficiency.
****
Chapters
00:00 Introduction to Digital Opinion Leaders
01:55 The Shift from KOLs to DOLs
03:33 Understanding Pharma's Engagement with DOLs
07:18 Challenges and Opportunities in Digital Engagement
11:09 The Role of Medical Governance in DOL Engagement
15:24 Building Effective Relationships with DOLs
17:28 Practical Steps for Pharma Companies
20:20 Hot or Not: Challenging the Status Quo
***
🔗 Links for more insights:
https://viseven.com/key-opinion-leaders-in-pharma/https://viseven.com/healthcare-marketing-plan-guide/https://viseven.com/patient-engagement-in-pharma/https://viseven.com/pharma-crm/https://viseven.com/mlr-review-process-in-pharma-challenges-and-solutions/https://viseven.com...
In this episode of PharmaTalks, Nataliya Andreychuk and Nico Renner discuss the evolving landscape of pharma marketing, particularly focusing on the concept of omnichannel marketing.
They explore the challenges and misconceptions surrounding omnichannel strategies, the importance of personalization versus segmentation, and the role of AI in enhancing marketing efforts. The conversation emphasizes the need for a more human touch in marketing and practical steps that pharma teams can take to improve their strategies.
Nico Renner is strictly sharing is personal views and opinion as an individual, not his current employer’s position on the discussed topics.
Takeaways
Omnichannel marketing is often misunderstood and overhyped.
Personalization should be distinct from segmentation in marketing.
The human element in marketing is crucial for effective engagement.
AI can help streamline marketing processes but should focus on relevance.
Pharma marketers face increasing pressure to be multifaceted experts.
Segmentation can be more effective than personalization at scale.
The industry needs to recalibrate its expectations from omnichannel strategies.
Marketers should prioritize creating relevant content over sheer volume.
The future of pharma marketing lies in understanding patient needs better.
A more human touch in marketing will be increasingly valued.
Chapters
00:00 Introduction to Omnichannel Marketing in Pharma
02:08 The Evolution of Pharma Marketing
04:46 Rethinking Omnichannel: Overrated or Misunderstood?
08:18 Personalization vs. Segmentation: A Misalignment?
19:22 Practical Steps for Pharma's Future
24:33 Hot or Not: Myths in Pharma Marketing
🔗 Links for more insights:
https://viseven.com/omnichannel/
https://viseven.com/content-development/
https://viseven.com/difference-multichannel-omnichannel-pharma-communication-many-overlooked/
https://viseven.com/using-omnichannel-approach-to-achieve-better-hcp-engagement-how-does-it-work/
Contact Viseven experts to e...
In this engaging conversation, Nataliya Andreychuk and Paul Tunnah discuss the evolving landscape of the pharmaceutical industry as they approach 2026. They explore the importance of digital transformation, emphasizing the need for a human-centric approach rather than a technology-first mindset.
The discussion delves into the risks and rewards associated with AI in pharma, the significance of customer engagement, and the challenges of hyper-personalization versus effective segmentation.
Takeaways
Digital transformation must prioritize human change over technology.
AI presents both risks and rewards that need careful consideration.
Customer engagement strategies should focus on building trust and connection.
Segmentation is crucial for effective communication in pharma.
Hyper-personalization may not be the best approach for all situations.
Content quality is essential to cut through the noise in marketing.
Companies should embrace a mindset of continuous evolution and adaptation.
Collaboration between IT and business leaders is vital for success.
The future of pharma will require a balance between technology and human insight.
2026 will be a pivotal year for the pharmaceutical industry.
Chapters
00:00 Introduction and Year-End Reflections
03:05 Digital Transformation and the Human Element
05:48 AI, Risk, and Reward in Pharma
08:35 Customer Engagement and the Future
11:28 Navigating AI and Content Creation
14:22 Hyper-Personalization vs. Segmentation
17:04 Hot or Not: Industry Predictions
25:52 Conclusion and Looking Ahead to 2026
Watch, listen, and reflect before you plan your 2026 strategy
Discover how AI is reshaping pharma – from marketing automation to intelligent sales strategies – with our guest Fredrik Holmboe. Listen to the new Pharma Talks episode with Nataliya Andreychuk!
Together, they explore how the role of the modern marketeer is evolving – from content creators to AI-driven orchestrators of omnichannel engagement. The conversation uncovers how AI in sales and marketing is reshaping daily operations, driving smarter decisions, and creating a seamless bridge between sales, marketing, and medical teams.
Key topics explored in this episode:
The shift from traditional marketing to AI and digital marketing approaches.How AI for sales and marketing empowers teams with predictive insights and real-time personalization.Practical examples of AI-driven sales enablement and content intelligence tools improving HCP engagement.Bridging organizational silos through data intelligence, automation, and AI for customer experience.Fredrik's ABC+ Content Excellence Framework – helping life science companies enhance digital engagement in pharma and ensure unified messaging across all channels.What the future holds for AI adoption in life science, pharma business transformation, and human-AI co-creation.
Tune in to discover where creativity meets intelligence, and technology becomes the enabler of more meaningful healthcare communication!
Find out more about ABC+ Content Excellence Framework: https://www.dualia.se/
Contact Viseven experts to elevate your healthcare marketing strategy: Viseven Pharma Marketing Team: 24/7 Expert Support
Discover more platforms to listen to this podcast: https://rss.com/podcasts/pharma-talks/
***
0:00 Intro
03:14 The evolving role of marketers in Pharma
06:09 Real-world applications of AI in marketing
17:17 Bridging gaps: sales, marketing, and medical collaboration
22:59 The future of marketing: orchestrating AI tools
***
Follow Viseven, Nataliya, and Fredrik in social media:
https://www.linkedin.com/company/viseven/...
In this episode, Viseven leaders reflect on the trends shaping the pharmaceutical industry today. The discussion focuses on how digital transformation is evolving from isolated initiatives into connected systems that support real business execution. Automation and AI are no longer optional, but their value depends on how well they are integrated into existing workflows and operating models.
This episode looks ahead to what’s next for pharma and life sciences, and what it takes to operationalize AI in a way that strengthens teams rather than replaces them.
Key topics explored in this episode:
The pharmaceutical industry is increasingly focusing on digital transformation and automation.Companies are rationalizing their systems to integrate AI more effectively.AI should be part of the core processes, not a separate entity.People and processes are crucial for successful tech integration.2026 will see a shift from AI pilots to operationalized solutions.AI will be integrated into teams to enhance productivity.The role of professionals will evolve to be more technology-savvy and cross-functional.There are challenges in balancing AI capabilities with human creativity.The industry must adapt quickly to the changing landscape of AI.Strategic thinking in the AI era requires a new approach to roles and responsibilities.***
Contact Viseven experts to elevate your healthcare marketing strategy: Viseven Pharma Marketing Team: 24/7 Expert Support
Discover more platforms to listen to this podcast: https://rss.com/podcasts/pharma-talks/
***
00:00 Introduction to Pharma Talks and Team Insights 00:56 Trends in Pharma: Digital Transformation and Automation 03:04 The Role of People and Processes in Tech Integration 05:08 Forecasting 2026: Operationalizing AI in Pharma 08:27 Challenges and Opportunities in the AI Era
***
Follow Viseven, Nataliya in social media:
https://www.linkedin.com/company/viseven/
https://www.linkedin.com/in/andreychuk/
The discussion between Nataliya and Paul serves as a reminder that the pharmaceutical industry stands at a crossroads where embracing change can lead to unprecedented opportunities. By trusting their creativity, shifting their mindsets, and focusing on quality over quantity, professionals can navigate the evolving landscape and make a lasting impact in healthcare.
Key topics explored in this episode:
Technological change should be embraced, not feared.
Understanding customer needs is crucial for innovation.
Pharma must trust its own capabilities and creativity.
Predictions for the future should be bold and visionary.
Quality of content is more important than quantity.
Compliance should be integrated into marketing strategies.
Agility in launch strategies is essential for success.
A human-centric approach is vital in the age of AI.
Patient-centricity must be balanced with scientific integrity.
Proactive engagement with technology will shape the future of pharma.
Chapters
00:00 Introduction and Overview of Pharma's Future
02:31 Embracing Change in Pharma
05:16 The Role of Customer Insights
08:00 Trusting Ourselves in Pharma Marketing
10:50 Predictions for 2026: A Visionary Outlook
13:42 Content Production and Its Evolution
16:24 The Future of Compliance in Pharma
19:12 Rethinking Launch Strategies
23:13 Embracing Agility and Evolution in Marketing
25:00 The Human Element in AI Integration
27:40 Navigating the Future of Work and Technology
29:41 Rethinking Patient-Centricity in Healthcare
33:44 Rapid Fire Insights on Industry Trends
Listen in for sharp insights, real-world experience, and a rapid-fire round that challenges some of omnichannel’s most common assumptions.
Contact Viseven experts to elevate your healthcare marketing strategy: Viseven Pharma Marketing Team: 24/7 Expert Support Discover more platforms to listen to this podcast: https://rss.com/podcasts/pharma-talks/ ***
Follow Viseven, Nataliya, and Paul in social media: https://w...
In this episode of Pharma Talks, Nataliya Andreychuk sits down with Yacin Marzouki for an honest conversation about why omnichannel in pharma still feels more complicated than it should be.
The discussion goes beyond tools and tactics. Nataliya and Yacin explore blind spots inside pharma teams, the shift toward a true business-to-healthcare mindset, and what omnichannel maturity actually looks like in practice.
Key topics explored in this episode:
Omnichannel strategies in pharma need to evolve for success.Understanding HCPs' needs is crucial for effective engagement.Blind spots in data and insights hinder omnichannel effectiveness.Content strategy must be connected across all channels.Technology alone cannot solve omnichannel challenges.Local differences impact omnichannel strategies significantly.Emotional tech and empathy are the future of engagement.Chapters
00:00 Introduction to Omnichannel in Pharma 02:28 Guest Introduction and Background 05:20 Identifying Blind Spots in Pharma 11:57 Understanding HCP Needs and Engagement 16:12 Maturity Levels of Omnichannel Strategies 21:04 The Role of Content and Technology 28:45 Rapid Fire Round: Hot or Not
Listen in for sharp insights, real-world experience, and a rapid-fire round that challenges some of omnichannel’s most common assumptions.
Contact Viseven experts to elevate your healthcare marketing strategy: https://viseven.com/contact-us/
Discover more platforms to listen to this podcast: https://rss.com/podcasts/pharma-talks/
***
Follow Viseven, Nataliya, and Fredrik in social media:
https://www.linkedin.com/company/viseven/
https://www.linkedin.com/in/andreychuk/
https://www.linkedin.com/in/fredrikholmboe/
***
🔗 Links for more insights:
https://viseven.com/ai-data/
https://viseven.com/healthcare-data-analytics/
https://viseven.com/ai-medical-affairs/
https://viseven.com/list-of-ai-mistakes-pharma-companies-make/
In this episode of Pharma Talks, Nataliya Andreychuk, CEO of Viseven, welcomes Alejandro Jaramillo, Head of Data Science, Insights & Analytics to discuss how AI-driven pharma decisions are redefining every aspect of the pharmaceutical industry.
Together, they dive deep into how AI-driven pharmaceutical innovation is helping organizations move beyond simple dashboards toward predictive, data-led decision-making. They explore how AI in pharma enables smarter forecasting, improves drug development automation, and supports a more patient-centric approach – all while staying compliant with regulatory frameworks like HIPAA and GDPR.
Key topics explored in this episode:
• The shift from descriptive analytics to AI-driven decision-making in pharma.
• How predictive analytics and real-world evidence enhance outcomes across the pharma digital ecosystem.
• Managing ethical AI in healthcare and ensuring pharma data governance in a regulated environment.
• The evolution of next-gen pharma leadership – why empathy, collaboration, and data fluency define future-ready leaders.
• The role of AI personalization in simplifying engagement with HCPs and patients while maintaining compliance.
Tune in now!
Contact Viseven experts to elevate your healthcare marketing strategy:
https://viseven.com/contact-us/
***
Follow Viseven, Nataliya, and Alejandro in social media:
https://www.linkedin.com/company/viseven/
https://www.linkedin.com/in/andreychuk/
https://www.linkedin.com/in/aljaramillo/
***
Case studies mentioned by Alejandro:
https://www.aktana.com/resources/case-study-nba-activation/?utm_source=chatgpt.com
https://www.nature.com/articles/s41598-021-98387-w?utm_source=chatgpt.com
https://www.pharmaceuticalcommerce.com/view/applying-ai-case-studies-in-pharma?utm_source=chatgpt.com
https://www.frontiersin.org/journals/digital-health/articles/10.3389/fdgth.2025.1523070/full?utm_source=chatgpt.com
***
🔗 Links for more insights:
https://viseven.com/ai-data/
https://viseven.com/healthcar...
In this episode of Pharma Talks, Nataliya Andreychuk sits down with Steve Swan, founder and CEO of The Swan Group Executive Search, to discuss how to attract and retain AI talent in pharma.
As pharma integrates AI-driven healthcare solutions and adapts new business models, the demand for AI experts in pharma and life sciences AI talents is at an all-time high. Yet, pharma HR strategies face a unique challenge: competing with big tech and finance for top digital health expertise.
Steve shares insights from 26+ years in executive search for biotech and pharmaceutical firms, covering:
Why pharmaceutical AI talents are critical for clinical trials, R&D efficiency, and commercial strategy.How life sciences hiring challenges differ from other industries – and why mission-driven candidates often choose pharma.The rising importance of hybrid roles bridging business and IT, redefining pharmaceutical leadership.The "work in the middle" of recruitment that AI cannot replace – human judgment, empathy, and cultural fit.Future trends: from Chief AI Officer roles to evolving digital healthcare careers in pharma and biotech.Whether you're navigating AI recruitment in pharma, rethinking your pharma HR strategies, or planning your next phase of pharma industry innovation, this episode provides actionable insights into building the future pharma workforce.
Contact Viseven experts to elevate your healthcare marketing strategy: https://viseven.com/contact-us/
Find out more about Swan Group: https://swangroup.net/
***
Follow Viseven, Nataliya, and Steve in social media:
https://www.linkedin.com/company/viseven/
https://www.linkedin.com/in/andreychuk/
https://www.linkedin.com/in/swangroup/
***
🔗 Links for more insights:
https://viseven.com/our-team/
https://viseven.com/ai-data/
https://viseven.com/case-studies/ai-chatbot-development/
https://viseven.com/artificial-intelligence-in-pharma-industry/
In this episode of Pharma Talks, Nataliya Andreychuk once again welcomes Thomas Mrosk and Manuel Mitola, co-founders of ctcHealth, to dive deep into one of the most transformative topics in life sciences today – AI personal assistants for pharma teams.
With decades of combined experience in pharma innovation, digital transformation pharma, and AI adoption, Thomas and Manuel share their perspectives on how AI agents are reshaping the way sales reps, brand managers, and marketers work in highly regulated environments. Key topics explored in this episode:
• What is an AI agent? A clear breakdown of how agent AI works in the context of pharma and why it’s more than just another tool.
• How to build an AI agent and how to create an AI agent: From evaluating infrastructure and compliance frameworks to piloting small, task-oriented assistants.
• Practical examples of AI agent assist: Automating CRM data entry, supporting sales calls, enabling pre-call planning, and accelerating content creation.
• AI agent frameworks and multi-agent systems: How combining multiple AI-powered pharma solutions can support complex processes like brand launches, campaign management, and cross-functional collaboration.
• The importance of human-in-the-loop AI: Why compliance, medical review, and brand voice remain critical in AI agent development services.
• Challenges and guardrails: Addressing AI hallucinations, fine-tuning models with domain knowledge, and designing intuitive AI agent software for user adoption.
• Exploring the potential of AI customer service agents in pharma to enhance engagement while staying compliant.
Tune in this AI healthcare podcast to explore how AI agents and humans work side by side to drive smarter, faster, and more compliant innovation!
Find out more about Viseven and ctcHealth AI-driven partnership: https://viseven.com/press-release/viseven-ctchealth-partnership/
Contact Viseven experts to elevate your healthcare marketing strategy:
https://viseven.com/contact...
In this episode of the Pharma Talks, Nataliya Andreychyk welcomes Katrine Bach for an inspiring conversation on how women leaders in AI and healthcare are transforming the pharma industry and shaping the future of patient care.
Katrine also shares the story behind her Connected Women in AI community – a global network that empowers women driving change in data, AI, and healthcare innovation. Through this initiative, she highlights how women leaders in AI are supporting one another, advancing AI ethics, and accelerating digital solutions.
This episode highlights how artificial intelligence trends and life sciences AI are redefining the way we think about healthcare disruption and the future of pharma. With a focus on women entrepreneurs in healthcare, the discussion shines a light on real examples of empowering women in pharma, their influence on data and AI strategy, patient-centric innovation, and the opportunities ahead for digital transformation.
Tune in to discover how women driving change are at the heart of building smarter, more inclusive, and impactful AI for healthcare.
Find out more about Connected Women In AI: https://www.connectedwomeninai.dk/
Contact Viseven experts to elevate your healthcare marketing strategy: https://viseven.com/contact-us/
***
Follow Viseven, Nataliya, Katrine, and Connected Women In AI in social media:
https://www.linkedin.com/company/viseven/
https://www.linkedin.com/in/andreychuk/
https://www.linkedin.com/in/katrinebach/?originalSubdomain=dk
dk.linkedin.com/company/connected-women-in-ai
***
🔗 Links for more insights:
https://viseven.com/ai-data/
https://viseven.com/healthcare-data-analytics/
https://viseven.com/podcast/ai-changes-pharma/
https://viseven.com/artificial-intelligence-in-pharma-industry/
Why should pharma companies rethink strategies that already work? In this episode of Pharma Talks, Nataliya Andreychuk is joined by Tara DeBellis to discuss why changes in the pharmaceutical industry are no longer optional but necessary for growth and sustainability.
From evolving life sciences strategy to addressing regulatory changes and patient expectations, Nataliya and Tara uncover the signs that it's time to evolve.
You'll learn:
• How to spot early warning signs that your processes are holding back innovation.
• Why pharma transformation isn't just about tools, but about smarter collaboration, omnichannel orchestration, and rethinking campaign execution.
• Common myths about digital health and pharma trends, and how to separate hype from meaningful change.
• Real-world lessons from healthcare marketing that highlight the risks of standing still.
This episode is a must-listen for leaders navigating pharmaceutical industry changes, life sciences innovation, and healthcare change in an era of fast-moving digital disruption.
Contact Viseven experts to elevate your healthcare marketing strategy: https://viseven.com/contact-us/
***
Follow Viseven, Nataliya, and Tara in social media: https://www.linkedin.com/company/viseven/
https://www.linkedin.com/in/andreychuk/
https://www.linkedin.com/in/tara-debellis-3476831bb/
***
🔗 Links for more insights:
https://viseven.com/pharma-change-management/
https://viseven.com/omnichannel/
https://viseven.com/digital-transformation-in-pharma/
https://viseven.com/7-core-components-of-successful-global-marketing-strategy/
In this episode of Pharma Talks, we take a deep dive into how AI changes the very foundation of the pharmaceutical industry. Together with Patrick Markt-Niederreite from Zero‑Click Healthcare, Nataliya explores what it truly means to move toward an AI-first pharma model – one that redefines how companies operate, communicate, and grow.
More than just AI in pharma, this conversation unpacks how artificial intelligence is transforming everything from content creation to team dynamics and executive decision-making. You'll hear how AI is being used not as a bolt-on feature but as a driver of end-to-end pharma digital transformation, where workflows, roles, and success metrics are all being reimagined.
Nataliya and Patrick also explore the importance of shifting from traditional output-focused KPIs to data-driven pharma decisions based on real-time feedback and decision-making automation.
Throughout the episode, you'll gain insights into what using AI in pharma really looks like, how it supports AI-driven teams, and why a strong healthcare AI strategy is essential for companies aiming to compete in an increasingly digital market.
Contact Viseven experts to elevate your healthcare content strategy: https://viseven.com/contact-us/
***
0:00 Intro
02:11 AI first mindset in pharma
05:26 The role of AI in content creation
08:22 Evolving KPIs and learning cycles
11:43 Speed of testing and scaling
18:03 Democratizing technology in pharma
23:35 Advice for AI innovation journey
***
Follow Viseven, Nataliya, and Patrick in social media:
https://www.linkedin.com/company/viseven/
https://www.linkedin.com/in/andreychuk/
https://www.linkedin.com/in/patrick-markt-niederreiter-41539959/
***
🔗 Links for more insights:
https://viseven.com/ai-data/
https://viseven.com/artificial-intelligence-in-pharma-industry/
https://viseven.com/ai-in-life-sciences/
Explore the real story of pharma digital transformation. Hear from Paul Tunnah on how content, tech, and strategy are reshaping the pharma industry.
From content transformation to the latest digital transformation trends in pharma, this episode unpacks what's working, what's evolving, and what's next.
Nataliya and Paul explore the shift towards digital content transformation, how AI in pharma is accelerating pharmaceutical innovation to understand the role of pharma digital tools and regulatory digital shifts in today's healthcare landscape.
Whether you're focused on healthcare technology, medical communication trends, or modernizing pharma marketing, this is your front-row seat to the future of the industry.
Tune in to learn how pharma is not just going digital – but transforming for good.
Contact Viseven experts to elevate your healthcare content strategy: https://viseven.com/contact-us/
Discover more platforms to listen to this podcast: https://rss.com/podcasts/pharma-talks/
Also, don’t miss the newly published book on CX in pharma by Paul Tunnah and Faisal Ahmed – now available here: https://www.amazon.co.uk/Prescription-Success-Delivering-Exceptional-Pharmaceutical/dp/B0FD7FBLH9
***
0:00 Intro
02:47 The challenges of the current content supply chain
05:36 Balancing creativity and compliance
09:02 Europe vs. US: approaches to content production
12:15 AI's role in MLR acceleration
16:21 Consistency in content approval
19:20 Big Pharma's role in AI transformation
23:02 Collaboration for future success
***
Follow Viseven, Nataliya, and Paul in social media:
https://www.linkedin.com/company/viseven/
https://www.linkedin.com/in/andreychuk/
https://www.linkedin.com/in/paultunnah/
***
🔗 Links for more insights:
https://viseven.com/customer-centric-digital-transformation/
https://viseven.com/digital-transformation-in-pharma/
https://viseven.com/ai-data/
https://viseven.com/content-development/
https://viseven.com/podcast/bayer-modular-content-transformation/
Explore why pharma resists change, how to align stakeholders, and scale transformation – with Cecilia Baeza on Pharma Change Management.
In this fresh episode of Pharma Talks, Nataliya and Cecilia dive deep into the human side of pharmaceutical change management: how to overcome adoption barriers and what it takes to lead a successful digital transformation in pharma.
Cecilia shares real-world insights on aligning cross-functional stakeholders, boosting employee buy-in, and building internal momentum – from pilot to scale.
This episode is a must-watch for pharma professionals involved in change control management in the pharmaceutical industry, digital transformation, and change management for pharma sales forces. Discover how organizational change, internal communication, and pharma culture shifts can become powerful levers for innovation.
Whether you're leading a pharma transformation strategy, implementing a change management system in pharma, or working on stakeholder engagement for large-scale rollouts, this conversation offers real-world insights and actionable advice.
#pharmatalks #pharmaleadership #changemanagement #organizationalchange
Contact Viseven experts to elevate your healthcare content strategy: https://viseven.com/contact-us/
***
Follow Viseven, Nataliya, and Cecilia in social media:
https://www.linkedin.com/company/viseven/
https://www.linkedin.com/in/andreychuk/
https://www.linkedin.com/in/ceciliabaeza-castro/
***
🔗 Links for more insights:
https://viseven.com/digital-transformation-in-pharma/
https://viseven.com/technology-consulting/
https://viseven.com/healthcare-web-development/
https://viseven.com/healthcare-data-analytics/
In this episode, we focus the complexities of scaling omnichannel strategies in pharma, especially across global markets. Join Nataliya Andreychuk and Franck Mayet, Digital Transformation and Customer Engagement Expert, as they explore the real-world challenges pharma companies face when implementing omnichannel engagement in pharma, including regional limitations, geographic agility, and cultural nuances that make a one-size-fits-all strategy ineffective.
Learn how leading organizations are leveraging data-driven decision-making to enhance pharma performance tracking, improve operational efficiency, and ensure successful pharma omnichannel transformation. We also address the critical role of data transparency and collaboration between vendors and pharma companies in optimizing global campaigns and strategy execution.
Whether you're refining your omnichannel strategy in pharma or navigating the complexities of multichannel engagement across markets, this episode offers valuable insights into what it really takes to transform omnichannel marketing in pharma at scale.
Contact Viseven experts to elevate your healthcare content strategy: https://viseven.com/contact-us/
***
Follow Viseven, Nataliya, and Franck in social media:
https://www.linkedin.com/company/viseven/
https://www.linkedin.com/in/andreychuk/
https://www.linkedin.com/in/franckmayet/
***
🔗 Links for more insights:
https://viseven.com/omnichannel/
https://viseven.com/pharma-professional-services/
https://viseven.com/omnichannel-kpi/
https://viseven.com/omnichannel-communication-strategy/
https://viseven.com/pharmaceutical-industry-challenges/
https://viseven.com/healthcare-business-intelligence/
Explore how AI is transforming pharma marketing in this Pharma Talks podcast. Discover top AI tools delivering results and enhancing customer experience.
In this episode of Pharma Talks, Nataliya Andreychuk sits down with ctcHealth experts Thomas Mrosk, Founder & Managing Director, and Manuel Mitola, Partner & Head of AI Consulting, to explore the most impactful applications of AI in pharma marketing today.
Discover how artificial intelligence in pharmaceutical marketing is reshaping engagement strategies, optimizing pharma digital marketing, and enhancing customer personalization. From chatbots in healthcare to automation in pharma, our guests reveal which AI tools are delivering the best ROI and where the future of pharma AI marketing is headed.
Whether you're exploring AI marketing tools, AI-driven analytics, or the role of virtual assistants in healthcare, this episode is packed with data-driven strategies and expert insights. Tune in!
Contact Viseven experts to elevate your healthcare content strategy: https://viseven.com/contact-us/
Discover more platforms to listen to this podcast: https://rss.com/podcasts/pharma-talks/
Contact ctcHealth experts to get a free 15 mins consultation about how to adopt and use AI in Pharma Marketing: https://bit.ly/4cBCKlS
Follow Nataliya, Manuel, and Thomas in social media: https://www.linkedin.com/in/andreychuk/
https://www.linkedin.com/in/mitola/
https://www.linkedin.com/in/thomas-mrosk/
🔗 Links for more insights:
https://viseven.com/ai-data/
https://viseven.com/ai-enablement-services/
https://viseven.com/artificial-intelligence-in-pharma-industry/
https://viseven.com/ai-in-life-sciences/
https://viseven.com/podcast/centers-of-excellence/
